| NO. | Recommended Best Practice | Adoption Status |
Notes |
|---|---|---|---|
| 1 | Adoption of Corporate Governance Charter | O | Established in July 2022 |
| 2 | Adoption of Employee Code of Ethics | O | Established in March 2015 |
| 3 | Adoption and disclosure of cumulative voting system | X | Cumulative voting system not adopted |
| 4 | Composition of Board (Majority: outside directors) | O | 3 inside directors, 4 outside directors (accounting for 57%) |
| 5 | Separation of Representative Director and Board Chairperson |
O | Outside director appointed as Board Chair (since March 2018) |
| 6 | Distribution of Director CVs before meetings | O | Meeting materials sent in advance |
| 7 | Holding regular board meetings (more than quarterly) | O | At least once per quarter (per board protocol) |
| 8 | Disclosure of board activities, attendance, and voting results on major agenda items |
O | In annual, semi-annual, and quarterly reports and on the website |
| 9 | Establishment of Outside Director Nomination Committee | O | 1 inside director, 2 outside directors |
| 10 | Establishment of Compensation Committee (members are all outside directors) |
O | 3 outside directors |
| 11 | Establishment of Audit Committee (members are all outside directors) |
O | 3 outside directors |
| 12 | Establishment of Provisions for the Roles and Operating Procedures of the Board and Committees |
O | On the website |
| 13 | Subscription to D&O Insurance at the Dong-A ST's expense |
O | Subscribed to D&O Insurance |
| 14 | Assessment of board activities | O | - |
| 15 | Guaranteed independence of external auditors | O | - |
| 16 | Verification of the accuracy and integrity of Financial Statements by CEO and CFO |
O | - |
| 17 | Explanation for differences from the Best Practices | O | On the website |
| 18 | Disclosure of Audit Reports and ad hoc announcements (Korean and English) |
△ | Only in Korean |
| 19 | Establishment of CEO Succession Planning | O | - |
As of December 31,
2024 (unit: shares)
| Share Data | Types of Shares | Notes | ||
|---|---|---|---|---|
| Common Shares | Preferred Shares | Total | ||
| I.Total Authorized Shares | 30,000,000 | - | 30,000,000 | - |
| II.Total Number of Shares Issued to Date | 9,172,975 | 700,348 | 9,873,323 | - |
| III.Total Shares Decreased to Date | - | 700,348 | 700,348 | - |
| 1. Reduction of Capital | - | - | - | - |
| 2. Retirement of Shares | - | - | - | - |
| 3. Redemption of Shares | - | - | - | - |
| 4. Others | - | 700,348 | 700,348 | - |
| IV.Outstanding Shares (II-III) | 9,172,975 | - | 9,172,975 | - |
| V.Number of Treasury Shares | 189,436 | - | 189,436 | - |
| VI.Float Shares (IV-V) | 8,983,539 | - | 8,983,539 | - |
As of December 31,
2024 (unit: shares)
| Shareholders | Name | Types of Shares | Number of Shares Owned |
Percentage (%) |
|---|---|---|---|---|
| Largest Shareholders | Dong-A Socio Holdings and 16 affiliate persons | Common Shares | 2,489,132 | 27.14 |
| Major Shareholders | National Pension Service | Common Shares | 661,007 | 7.21 |
| Glaxo Group Limited | Common Shares | 722,016 | 7.87 | |
| Employee Stockholders Association | Common Shares | 564,156 | 6.15 | |
| Category | Adoption | Date of Adoption |
|---|---|---|
| Electronic Voting and Electronic Proxy Voting | Adopted | March 27, 2018 |
| Write-in Voting | Not adopted | - |
| Cumulative Voting | Excluded | - |
| Category | Type of Shares | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| 12th | 11th | 10th | 9th | 8th | ||
| Face Value per Share (KRW) | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | |
| (Consolidated) Net Income (Million KRW) | -23,235 | 2,021 | 12,771 | 12,816 | 27,103 | |
| (Separate) Net Income (Million KRW) | 15,136 | 17,299 | 9,020 | 11,969 | 27,653 | |
| (Consolidated) Earnings per Share (KRW) | -144 | 1,311 | 1,606 | 1,519 | 3,212 | |
| Total Cash Dividends (Million KRW) | 6,288 | 5,901 | 5,884 | 8,441 | 8,438 | |
| Total Stock Dividends (Million KRW) | 898 | 843 | 841 | - | - | |
| (Consolidated) Cash Dividends Payout Ratio (%) | - | 53.1 | 46.1 | 65.8 | 31.13 | |
| Cash Dividends Yield (%) | Common Shares | 1.4 | 1.1 | 1.1 | 1.4 | 1.2 |
| Preferred Shares | - | - | - | - | - | |
| Stock Dividends Yield (%) | Common Shares | 0.3 | 6.1 | 1.5 | - | - |
| Preferred Shares | - | - | - | - | - | |
| Cash Dividends per Share (KRW) | Common Shares | 700 | 700 | 700 | 1,000 | 1,000 |
| Preferred Shares | - | - | - | - | - | |
| Stock Dividends per Share (Shares) | Common Shares | 0.02 | 0.02 | 0.02 | - | - |
| Preferred Shares | - | - | - | - | - | |
| Agenda Item | Meeting Purpose | Resolution Type |
Approval Status |
Voting Rights Present |
Attendance Rate Excluding Major Shareholders and Affiliate Persons |
Votes in Favor | Votes Against /Abstentions |
|---|---|---|---|---|---|---|---|
| Agenda 1 | Approval of the 11th Financial Statements (Including Statement of Appropriation of Retained Earnings) and Consolidated Financial Statements | Ordinary Resolution | Approved | 5,263,298 | 24.6% | 5,183,474 | 79,824 |
| Agenda 2 | Appointment of Directors (Candidate for Inside Director : Jae-Hong Park) |
Ordinary Resolution | Approved | 5,263,298 | 24.6% | 5,240,737 | 22,561 |
| Agenda 3 | Appointment of an Outside Director as a Member of the Audit Committee (Candidate for Outside Director : Bum-Joon Kim) | Ordinary Resolution | Approved | 2,273,632 | 28.4% | 2,218,017 | 55,615 |
| Agenda 4 | Approval of Director Remuneration Limit | Ordinary Resolution | Approved | 5,263,256 | 24.6% | 4,575,220 | 688,036 |
| Agenda Item | Meeting Purpose | Resolution Type |
Approval Status |
Voting Rights Present |
Attendance Rate Excluding Major Shareholders and Affiliate Persons |
Votes in Favor | Votes Against /Abstentions |
|---|---|---|---|---|---|---|---|
| Agenda 1-1 | Appointment of Inside Director (Candidate: Jae-hun Jung) |
Ordinary Resolution | Approved | 4,499,887 | 27.0% | 3,908,418 | 591,469 |
| Agenda 1-2 | Appointment of Inside Director (Candidate: Dae-woo Lee) |
Ordinary Resolution | Approved | 4,499,887 | 27.0% | 4,488,913 | 10,974 |
| Agenda Item | Meeting Purpose | Resolution Type |
Approval Status |
Voting Rights Present |
Attendance Rate Excluding Major Shareholders and Affiliate Persons |
Votes in Favor | Votes Against /Abstentions |
|---|---|---|---|---|---|---|---|
| Agenda 1 | Approval of the 11th Financial Statements (Including Statement of Appropriation of Retained Earnings) and Consolidated Financial Statements |
Ordinary Resolution | Approved | 4,470,635 | 27.9% | 4,429,946 | 40,689 |
| Agenda 2 | Partial Amendment to the Articles of Incorporation | Special Resolution | Approved | 4,470,635 | 27.9% | 4,469,893 | 742 |
| Agenda 3-1 | Appointment of Directors (Candidate for Outside Director: Dong-chul Kim) |
Ordinary Resolution | Approved | 4,470,635 | 27.9% | 4,469,183 | 1,452 |
| Agenda 3-2 | Appointment of Directors (Candidate for Outside Director: Byung-won Jang) |
Ordinary Resolution | Approved | 4,470,635 | 27.9% | 4,469,183 | 1,452 |
| Agenda 4-1 | Appointment of Audit Committee Member (Candidate for Audit Committee Member: Dong-chul Kim) |
Ordinary Resolution | Approved | 1,841,776 | 27.9% | 1,840,324 | 1,452 |
| Agenda 4-2 | Appointment of Audit Committee Member (Candidate for Audit Committee Member: Byung-won Jang) |
Ordinary Resolution | Approved | 1,841,776 | 27.9% | 1,840,324 | 1,452 |
| Agenda 5 | Approval of Director Remuneration Limit | Ordinary Resolution | Approved | 4,470,635 | 27.9% | 4,468,865 | 1,770 |
1) Submission Deadline: At least six weeks prior to the date of the year corresponding to the date of the ordinary general meeting of shareholders of the preceding year
2) Method: Written or electronic document
※ Address: Shareholders’ Meeting Manager, Business Planning Office, Dong-A ST, 64 Cheonho-daero, Dongdaemun-gu, Seoul
E-mail: ir@donga.co.kr
3) Qualification Requirements (choose one)
1. Shareholders holding at least 3% of the total voting shares
(Based on Article 363-2, Paragraph 1 of the Commercial Act)
2. Shareholders holding at least 1% of the total voting shares continuously for 6 months or more
(Based on Article 542-6, Paragraph 2 of the Commercial Act)
※ In determining the qualification of shareholder holdings, the period starts from the day before the date of claiming a shareholder proposal (either written or electronic) to now. - Required Documents: Certificate of actual shareholder status and transaction history issued by the Korea Securities Depository (support document)
Once a shareholder proposal is received, a legal review of the proposal and shareholder's qualifications is carried out to determine whether to raise the item at the general meeting of the shareholder, which will be informed to the shareholders in writing or electronically. When the proposal is included in the meeting agenda, the proposing shareholder will be given an opportunity to explain it at the shareholders' meeting.
1) If a proposal is a repetition from a previous meeting (within 3 years) where it only garnered less than 10% of the votes in favor
2) If the proposal concerns the personal grievances of the shareholder.
3) If the proposal relates to minority shareholders’ rights requiring ownership of shares exceeding a certain percentage.
4) If the proposal concerns the dismissal of an incumbent executive during their term.
5) If the proposal is for matters the company cannot materialize or be motivated by false claims or defamation towards specific individuals.
As of March 31, 2025
| Jae-hun Jeong (Representative Director) |
Appointment Date: August 8, 2024 President of Dong-A ST Master’s in Pharmacy from Sungkyunkwan University |
Term: 3 years |
|---|---|---|
| Jae-hong Park |
Appointment Date: March 31, 2025 President of Dong-A ST Harvard Medical School : Institute of |
Term: 3 years |
| Dae-woo Lee |
Appointment Date: August 8, 2024 Director of Business Planning and Management of Dong-A ST International Economy, Seoul National University |
Term: 3 years |
As of March 31, 2025
| Byung-won Jang (Chairperson of the Board) |
Appointment Date: March 26, 2024 Special Professor at Ajou University College of Pharmacy Vice President of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association |
Term: 3 years |
|---|---|---|
| Hak-joon Kim |
Appointment Date: March 28, 2023 CEO of Yeouido Administrative Firm Master’s in Social Pharmacy from Sungkyunkwan University |
Term: 3 years |
| Dong-chul Kim |
Appointment Date: March 26, 2024 Managing Partner at Law Firm (LLC) Hyun Member of the Seoul Private Investment Project Evaluation Committee |
Term: 3 years |
| Bum-joon Kim |
Appointment Date: March 31, 2025 Professor of Accounting at the Catholic University of Korea Member of Statutory Interpretation Deliberation Committee, Financial Services Commission |
Term: 3 years |
| No. | Date | Agenda | Recognition | Name of the Directors | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jae-hoon Jung (Attendance rate: 100%) |
Jae-hong Park (Attendance rate: 83.3%) |
Dae-woo Lee (Attendance rate: 100%) |
Byung-won Jang (Attendance rate: 100%) |
Bum-joon Kim (Attendance rate: 100%) |
Hak-joon Kim (Attendance rate: 100%) |
Dong-chul Kim (Attendance rate: 100%) |
||||
| Agree/Disagree | ||||||||||
| 1 | 2025.02.06 | Approval of Separate Financial Statements and Annual Business Report for the 12th Term | Approved | Agree | Agree | Agree | Agree | Agree | Agree | Agree |
| Resolution on Prior Approval of a Director’s Self-Dealing Transaction | Approved | Attended | Agree | Attended | Agree | Agree | Agree | Agree | ||
| Report on the Results of the 2024 ISO37001 CEO review | - | Attended | Attended | Attended | Attended | Attended | Attended | Attended | ||
| 2 | 2025.02.19 | Approval of the Consolidated Financial Statements for the 12th Term | Approved | Agree | Agree | Agree | Agree | Agree | Agree | Agree |
| Determination of the Record Date for Dividends | Approved | Agree | Agree | Agree | Agree | Agree | Agree | Agree | ||
| Declaration of Stock Dividends | Approved | Agree | Agree | Agree | Agree | Agree | Agree | Agree | ||
| Report on 2024 Business Performance and 2025 Business Plan | - | Attended | Attended | Attended | Attended | Attended | Attended | Attended | ||
| Report on the Operation status of the Internal Accounting Management System by the CEO | - | Attended | Attended | Attended | Attended | Attended | Attended | Attended | ||
| 3 | 2025.02.27 | Convocation of the 12th Annual General Meeting of Shareholders | Approved | Agree | Agree | Agree | Agree | Agree | Agree | Agree |
| 4 | 2025.03.06 | Resolution on the Establishment of a Joint Venture Company in Japan | Approved | Agree | Absence | Agree | Agree | Agree | Agree | Agree |
| Resolution on Delegation to the CEO for Execution and Extension Approval of Loans in 2025 | Approved | Agree | Absence | Agree | Agree | Agree | Agree | Agree | ||
| Execution of New Bank loans | Approved | Agree | Absence | Agree | Agree | Agree | Agree | Agree | ||
| Report on the results of the 2024 Board of Directors' Evaluation | - | Attended | Absence | Attended | Attended | Attended | Attended | Attended | ||
| Report on the Operation of the 2024 Sub-Committee under the Board of Directors | - | Attended | Absence | Attended | Attended | Attended | Attended | Attended | ||
| Evaluation Report on the Operation of the Internal Accounting Management System by the Audit Committee | - | Attended | Absence | Attended | Attended | Attended | Attended | Attended | ||
| 5 | 2025.04.22 | Resolution on the Composition of Board Committees | Approved | Agree | Agree | Agree | Agree | Agree | Agree | Agree |
| Report of 1Q 2025 Business Performances | - | Attended | Attended | Attended | Attended | Attended | Attended | Attended | ||
| Report on Safety and Health Management for 2024 and 2025 | - | Attended | Attended | Attended | Attended | Attended | Attended | Attended | ||
| Report on R&D Status of Dong-A ST | - | Attended | Attended | Attended | Attended | Attended | Attended | Attended | ||
| 6 | 2025.05.08 | Participation in Capital Increase of MetaVia, Inc. | Approved | Agree | Agree | Agree | Agree | Agree | Agree | Agree |
2024년 5월 8일 기준
| No. | Date | Agenda | Recognition | Name of the Directors | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hee-ju Choi (Attendance rate: 100%) |
Jae-sang Ryu (Attendance rate: 100%) |
Hak-joon Kim (Attendance rate: 100%) |
Bum-joon Kim (Attendance rate: 100%) |
Min-young Kim (Attendance rate: 100%) |
Jae-hong Park (Attendance rate: 75%) |
Jae-hoon Jung (Attendance rate: 62.5%) |
Byung-won Jang (Attendance rate: 100%) |
Dong-chul Kim (Attendance rate: 100%) |
Dae-woo Lee (Attendance rate: 100%) |
||||
| Agree/Disagree | |||||||||||||
| 1 | 2024.02.07 | Separate Financial Statements and Business Report | Approved | Agree | Agree | Agree | Agree | Agree | Agree | Absent | - | - | - |
| Transaction Limits of Affiliate Person |
Approved | Agree | Agree | Agree | Agree | Agree | Attended | Absent | - | - | - | ||
| Unsecured Public Issues | Approved | Agree | Agree | Agree | Agree | Agree | Agree | Absent | - | - | - | ||
| Appointment of Self -Compliance Officer |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | Absent | - | - | - | ||
| ISO370041 CEO Review 2023 | - | Agree | Agree | Agree | Agree | Agree | Agree | Absent | - | - | - | ||
| 2 | 2024.02.23 | Approval of Consolidated Financial Statements for 11th BD |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | Absent | - | - | - |
| Convening of Regular General Shareholders' Meeting |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | Absent | - | - | - | ||
| Report on Business Performance 2023 |
- | Attended | Attended | Attended | Attended | Attended | Attended | Absent | - | - | - | ||
| Report on Current Internal Accounting Management System by Representative Director |
- | Attended | Attended | Attended | Attended | Attended | Attended | Absent | - | - | - | ||
| 3 | 2024.03.07 | Acquisition of Ecowin | Approved | Agree | Agree | Agree | Agree | Agree | Absent | Agree | - | - | - |
| Participation in AbTis recapitalization |
Approved | Agree | Agree | Agree | Agree | Agree | Absent | Agree | - | - | - | ||
| Representative Director Dlegated for Execution, Extension, and Refinancing of Bank Loans |
Approved | Agree | Agree | Agree | Agree | Agree | Absent | Agree | - | - | - | ||
| Board Committee operations in 2023 |
- | Attended | Attended | Attended | Attended | Attended | Absent | Attended | - | - | - | ||
| Evaluation Report by Audit Committee on Internal Accounting System |
- | Attended | Attended | Attended | Attended | Attended | Absent | Attended | - | - | - | ||
| 4 | 2024.04.24 | Appointment of Board Chairperson |
Approved | - | - | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - |
| Formation of Board Committees |
Approved | - | - | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - | ||
| Approval of Payment Guarantee for Dong-A CHAMMED |
Approved | - | - | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - | ||
| Investment and Joint Development in Idience Co., Ltd |
Approved | - | - | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - | ||
| Approval of Environmental Goals for the Year 2024 |
Approved | - | - | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - | ||
| Report on Q1 Business Performance |
- | - | - | Attended | Attended | Attended | Attended | Attended | Attended | Attended | - | ||
| Report on Evaluation of the Board of FY 2023 |
- | - | - | Attended | Attended | Attended | Attended | Attended | Attended | Attended | - | ||
| Report on ESG Materiality Assessment and ESG Operation Plan |
- | - | - | Attended | Attended | Attended | Attended | Attended | Attended | Attended | - | ||
| Report on Health and Safety Management for the Years 2023-2024 |
- | - | - | Attended | Attended | Attended | Attended | Attended | Attended | Attended | - | ||
| 5 | 2024.06.14 | Follow-ups for Execution, Extension, and Refinancing of Bank Loans of 2Q 2024 |
- | - | - | Attended | Attended | Attended | Attended | Attended | Attended | Attended | - |
| Execution of a Fresh Bank Loan |
Approved | - | - | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - | ||
| Investment in NeuroBo Pharmaceuticals |
Approved | - | - | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - | ||
| 6 | 2024.06.28 | Follow-ups for Recapitalization for NeuroBo Pharmaceuticals |
- | - | - | Attended | Attended | Attended | Attended | Attended | Attended | Attended | - |
| Acquisition of Stocks of Major Shareholders of Dong-A CHAMMED |
Approved | - | - | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - | ||
| Convening of 12th Extraordinary Meeting of Shareholders | Approved | - | - | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - | ||
| Determination of Base Record Date of the Extraordinary Meeting of hareholder |
Approved | - | - | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - | ||
| 7 | 2024.07.24 | Establishment of ESG Committee and Its Provisions |
Approved | - | - | Agree | Agree | Agree | Agree | Absence | Agree | Agree | - |
| Amendment of BOD Provisions |
Approved | - | - | Agree | Agree | Agree | Agree | Absence | Agree | Agree | - | ||
| Report on Q2 Business Performance |
- | - | - | Attended | Attended | Attended | Attended | Absence | Attended | Attended | - | ||
| 8 | 2024.08.08 | Appointment of Represen tative Director |
Approved | - | - | Agree | Agree | - | Absence | Agree | Agree | Agree | Agree |
| Formation of Board Committees |
Approved | - | - | Agree | Agree | - | Absence | Agree | Agree | Agree | Agree | ||
| Appointment of Self- Compliance Officer |
Approved | - | - | Agree | Agree | - | Absence | Agree | Agree | Agree | Agree | ||
| Prior Approval of Board Member's Involvement in Competitive Business |
Approved | - | - | Agree | Agree | - | Absence | Agree | Agree | Agree | Agree | ||
| 9 | 2024.09.03 | Approval of Asset Contribution for the Establishment of a Foundation | Approved | - | - | Agree | Agree | - | Agree | Agree | Agree | Agree | Agree |
| 10 | 2024.09.27 | Resolution on Prior Approval of a Director’s Self-Dealing Transaction | Approved | - | - | Agree | Agree | - | Agree | Attended | Agree | Agree | Agree |
| 11 | 2024.10.30 | Report of 3Q 2024 Business Performances | - | - | - | Attended | Attended | - | Attended | Attended | Attended | Attended | Attended |
| Follow-up Report on Execution and Extension/Refinancing of loans for 3Q 2024 | - | - | - | Attended | Attended | - | Attended | Attended | Attended | Attended | Attended | ||
| 12 | 2024.12.11 | Appointment of Compliance Manager | Approved | - | - | Agree | Agree | - | Agree | Agree | Agree | Agree | Agree |
| Extension of Maturity for Credit Line Loan | Approved | - | - | Agree | Agree | - | Agree | Agree | Agree | Agree | Agree | ||
| Conclusion of Joint Research Agreement | Approved | - | - | Agree | Agree | - | Agree | Agree | Agree | Agree | Agree | ||
| Proposal for Amendment of Internal Accounting Control Regulations | Approved | - | - | Agree | Agree | - | Agree | Agree | Agree | Agree | Agree | ||
| Follow-up Report on Execution and Extension/Refinancing of loans for 4Q 2024 | - | - | - | Attended | Attended | - | Attended | Attended | Attended | Attended | Attended | ||
| 13 | 2024.12.20 | Resolution on Prior Approval of a Director’s Self-Dealing Transaction | Approved | - | - | Agree | Agree | - | Agree | Attended | Agree | Agree | Agree |
2023년 3월 31일 기준
| Mee ting No. |
Date | Agenda | Approval Status | Name of the Directors | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hee-ju Choi (Attendance: 87.5%) |
Jae-sang Ryu (Attendance: 100%) |
Hak-joon Kim (Attendance: 100%) |
Bum-joon Kim (Attendance: 93.8%) |
Min-young Kim (Attendance: 100%) |
Jae-hong Park (Attendance: 87.5%) |
Sung-geun Lee (Attendance: 100%) |
Jae-hoon Jeong (Attendance: 75.0%) |
||||
| Voting Results | |||||||||||
| 1 | January 20, 2023 | Extension of Loans | Approved | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - |
| 2 | January 26, 2023 | Acquisition of Treasury Shares |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - |
| 3 | February 10, 2023 | Approval of Financial Statements for 10th BD |
Approved | Absent | Agree | Agree | Agree | Agree | Absent | Agree | - |
| Participation in Dong-A CHAMMED Recapitalization | Approved | Absent | Agree | Agree | Agree | Agree | Absent | Agree | - | ||
| Approval of Transaction Limit for Affiliate Persons |
Approved | Absent | Agree | Agree | Agree | Agree | Absent | Agree | - | ||
| 4 | February 24, 2023 | Report on Business Performance 2022 and Management Plans 2023 |
- | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - |
| Approval of 10th Financial Statements |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - | ||
| Convening of 10th Shareholders’ Meeting |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - | ||
| Approval of Payment Guarantee for Dong-A CHAMMED |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - | ||
| Report on Internal Accounting System Operations by Representative Director |
- | Attended | Attended | Attended | Attended | Attended | Attended | Attended | - | ||
| Report on Health and Safety Management Plan for the Year 2023 |
- | Attended | Attended | Attended | Attended | Attended | Attended | Attended | - | ||
| Amendment of BOD Provisions |
Approved | Attended | Attended | Attended | Attended | Attended | Attended | Attended | - | ||
| Report on ISO37001 CEO Review for the Year 2022 |
- | Attended | Attended | Attended | Attended | Attended | Attended | Attended | - | ||
| Report on ESG Materiality Assessment and Operation Plans |
- | Attended | Attended | Attended | Attended | Attended | Attended | Attended | - | ||
| 5 | March 9, 2023 | Evaluation Report by Audit Committee on Internal Accounting System |
- | Attended | Attended | Attended | Attended | Attended | Attended | Attended | - |
| 6 | March 15, 2023 | Execution of a Fresh Loan | Approved | Agree | Agree | Agree | Agree | Agree | Agree | Agree | - |
| 7 | April 11, 2023 | Approval of Issuance of 11th Unsecured Bond Public Offering |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | - | Agree |
| 8 | April 26, 2023 | Acquisition of Treasury Shares |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | - | Agree |
| Formation of Board Committees |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | - | Agree | ||
| Amendment of Audit Committee Provisions |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | - | Agree | ||
| Appointment of Managers | Approved | Agree | Agree | Agree | Agree | Agree | Agree | - | Agree | ||
| Report on Q1 Business Performance for the Year 2023 |
- | Attended | Attended | Attended | Attended | Attended | Attended | - | Attended | ||
| Report on Environmental Management for the Years 2022-2023 |
- | Attended | Attended | Attended | Attended | Attended | Attended | - | Attended | ||
| 9 | 2023.05.08 | Approval of Credit Extension | Approved | Agree | Agree | Agree | Agree | Agree | Agree | - | Agree |
| Approval of Credit Refinancing | Approved | Agree | Agree | Agree | Agree | Agree | Agree | - | Agree | ||
| 10 | May 26, 2023 | Approval of Existing Credit Refinancing |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | - | Agree |
| 11 | July 17, 2023 | Signing of Line of Credit Agreement |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | - | Agree |
| 12 | July 26, 2023 | Acquisition of Treasury Shares |
Approved | Absent | Agree | Agree | Absent | Agree | Agree | - | Agree |
| Establishment of Rules for CEO Succession |
Approved | Absent | Agree | Agree | Absent | Agree | Agree | - | Agree | ||
| Report on Q2 Business Performance for the Year 2023 |
- | Absent | Attended | Attended | Absent | Attended | Attended | - | Attended | ||
| Report on R&D Activities | - | Absent | Attended | Attended | Absent | Attended | Attended | - | Attended | ||
| 13 | September 26, 2023 | Approval of Payment Guarantee for Dong-A CHAMMED |
Approved | Agree | Agree | Agree | Agree | Agree | Absent | - | Absent |
| 14 | October 25, 2023 | Appointment of Compliance Officer |
Approved | Agree | Agree | Agree | Agree | Agree | Absent | - | Absent |
| Establishment of Compliance Control Standards |
Approved | Agree | Agree | Agree | Agree | Agree | Absent | - | Absent | ||
| Appointment of Executives | Approved | Agree | Agree | Agree | Agree | Agree | Absent | - | Absent | ||
| Report on Q3 Business Performance for the Year 2023 |
- | Attended | Attended | Attended | Attended | Attended | Absent | - | Absent | ||
| Acquisition of Treasury Shares |
- | Attended | Attended | Attended | Attended | Attended | Absent | - | Absent | ||
| 15 | 2023.12.08 | Decision on Stock Dividend | Approved | Agree | Agree | Agree | Agree | Agree | Agree | - | Absent |
| Determination of Dividends Record Date |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | - | Absent | ||
| 16 | December 19, 2023 | Decision on Acquisition of Existing Shares in AbTis |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | - | Absent |
| Decision on Acquisition of New Shares in AbTis |
Approved | Agree | Agree | Agree | Agree | Agree | Agree | - | Absent | ||
| 회차 | 개최일자 | 의안내용회차 | 가결 여부 |
이사의 성명 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 최희주 (출석률 100%) |
류재상 (출석률 100%) |
김학준 (출석률 100%) |
김범준 (출석률 100%) |
김민영 (출석률 100%) |
박재홍 (출석률 100%) |
이성근 (출석률 100%) |
김근수 (출석률 100%) |
엄대식 (출석률 100%) |
한종헌 (출석률 83.3%) |
||||
| 찬반여부 | |||||||||||||
| 1 | 2022.01.07 | 여신 연장 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | - | - | - | 찬성 | 찬성 | 찬성 | 찬성 |
| 2 | 2022.01.21 | 여신 연장 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | - | - | - | 찬성 | 찬성 | 찬성 | 찬성 |
| 3 | 2022.02.11 | 제9기 결산서류 승인의 건(별도) | 가결 | 찬성 | 찬성 | 찬성 | - | - | - | 찬성 | 찬성 | 찬성 | 찬성 |
| 4 | 2022.02.18 | 대표이사의 내부회계관리제도 운영실태 보고의 건 |
가결 | 찬성 | 찬성 | 찬성 | - | - | - | 찬성 | 찬성 | 찬성 | 찬성 |
| 5 | 2022.02.25 | 2021년 경영실적 및 2022년 경영계획 보고의 건 |
- | 참석 | 참석 | 참석 | - | - | - | 참석 | 참석 | 참석 | 불참 |
| 제9기 결산서류 승인의 건(연결) | - | 참석 | 참석 | 참석 | - | - | - | 참석 | 참석 | 참석 | 불참 | ||
| 감사위원회의 내부회계관리제도 운영실태 평가 보고의 건 |
- | 참석 | 참석 | 참석 | - | - | - | 참석 | 참석 | 참석 | 불참 | ||
| 2021년 ISO37001 최고 경영자 검토 결과 보고의 건 |
- | 참석 | 참석 | 참석 | - | - | - | 참석 | 참석 | 참석 | 불참 | ||
| 2021년 ESG평가 내용 및 운영현황 보고의 건 |
- | 참석 | 참석 | 참석 | - | - | - | 참석 | 참석 | 참석 | 불참 | ||
| 제9기 정기주주총회 소집의 건 | 가결 | 찬성 | 찬성 | 찬성 | - | - | - | 찬성 | 찬성 | 찬성 | 불참 | ||
| 특수관계자와의 거래 규모 사전 승인의 건 |
가결 | 찬성 | 찬성 | 찬성 | - | - | - | 찬성 | 찬성 | 찬성 | 불참 | ||
| 6 | 2022.03.21 | 사모사채 발행의 건 | 가결 | 찬성 | 찬성 | 찬성 | - | - | - | 찬성 | 찬성 | 찬성 | 찬성 |
| 신규 차입의 건 | 가결 | 찬성 | 찬성 | 찬성 | - | - | - | 찬성 | 찬성 | 찬성 | 찬성 | ||
| 7 | 2022.03.28 | 대표이사 선임의 건 | 가결 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | - | - | - |
| 이사회 내 위원회 구성의 건 | 가결 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | - | - | - | ||
| 8 | 2022.04.27 | 2022년 1분기 경영실적 보고의 건 |
- | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | - | - | - |
| 9 | 2022.05.09 | 여신 연장 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | - | - | - |
| 사모사채 발행의 건 | 가결 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | - | - | - | ||
| 한도대출 약정의 건 | 가결 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | - | - | - | ||
| 10 | 2022.07.27 | 기업지배구조헌장 제정의 건 | 가결 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | - | - | - |
| 동아제약 대구캠퍼스 자산 인수의 건 | 가결 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | - | - | - | ||
| 2022년 2분기 경영실적 보고의 건 | - | 참석 | 참석 | 참석 | 참석 | 참석 | 참석 | 참석 | - | - | - | ||
| 2022년 안전보건관리 계획 보고의 건 | - | 참석 | 참석 | 참석 | 참석 | 참석 | 참석 | 참석 | - | - | - | ||
| 11 | 2022.09.14 | 타법인 주식 취득의 건 | 가결 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | - | - | - |
| 12 | 2022.10.26 | 진단사업부 현물출자의 건 | 가결 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 참석 | 찬성 | - | - | - |
| 자기주식 취득의 건 | 가결 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 불참 | 찬성 | - | - | - | ||
| 주차장 부지 개발의 건 | 가결 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 불참 | 찬성 | - | - | - | ||
| 2022년 3분기 경영실적 보고의 건 | - | 참석 | 참석 | 참석 | 참석 | 참석 | 불참 | 참석 | - | - | - | ||
| 13 | 2022.12.21 | 주식배당 결정의 건 | 가결 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | 찬성 | - | - | - |
As of Aug. 8, 2024
| Committee | Member | Object and Authority |
|---|---|---|
| Evaluation & Compensation Committee | 3 Outside Directors |
Object : To secure transparency and be objective in deciding compensation for management Authority : To review processes of evaluating performance of the management, compensation plan, and execution |
| Committee for Recommending Candidates for Outside Director | 1 Inside Director 2 Outside Directors |
Object : To ensure fairness and independence in the process of recommending candidates for outside director Authority : To Recommend candidates for outside director |
| Audit Committee | 3 Outside Directors |
Object : To strengthen independency and specialty of audit organization Authority : To appoint director, auditor of subsidiaries, outside auditor |
| ESG Committee | 1 Inside Director 4 Outside Directors |
Object : Board-level decision-making from an ESG perspective and the pursuit of sustainable management Authority : Decisions regarding the establishment of ESG-related strategies, policies, goals, and guidelines, as well as the management and supervision of internal transactions with affiliated companies, major shareholders, and related parties. |
As of Mar. 31, 2025
| Name of Director | Audit Committee | Committee for Recommending Candidates for Outside Director |
Evaluation & Compensation Committee | ESG Committee |
|---|---|---|---|---|
| Jae-Hun Jung | - | ○ | - | - |
| Jae-Hong Park | - | - | - | - |
| Dae-Woo Lee | - | - | - | ○ |
| Bum-Joon Kim | ○ (Chairman) |
- | ○ | ○ (Chairman) |
| Hak-Joon Kim | - | ○ (Chairman) |
○ | ○ |
| Dong-Chul Kim | ○ | - | ○ (Chairman) |
○ |
| Byung-Won Jang (Chairman) |
○ | ○ | - | ○ |
As of Mar. 31, 2025
| Date | Agenda | Recognition | Member of the Committee | ||||
|---|---|---|---|---|---|---|---|
| Hak- Joon Kim (Attendance : 100%) |
Hee- Joo Choi (Attendance : 100%) |
Min- Young Kim (Attendance : 100%) |
Jae- Hun Jung (Attendance : 100%) |
Byung- Won Jang (Attendance : 100%) |
|||
| Agree/Disagree | |||||||
| 2024.02.23 | Designation of the Chairperson of Committee for Recommending Candidates for Outside Director Operation |
Approved | Agree | Agree | Agree | - | - |
| Recommendation of candidates outside directors for the 11th Annual General meeting of Shareholders |
Approved | Agree | Agree | Agree | - | - | |
| 2025.02.27 | Report on the Management of the Outside Director Candidate Pool for Dong-A ST | - | Attended | - | - | Attended | Attended |
| Recommendation of candidates outside directors for the 12th Annual General meeting of Shareholders |
Approved | Agree | - | - | Agree | Agree | |
As of Mar. 31, 2025
| Date | Agenda | Recognition | Member of the Committee | |||
|---|---|---|---|---|---|---|
| Jae- Sang Ryu (Attendance 100%) |
Dong- Chul Kim (Attendance 100%) |
Hak- Joon Kim (Attendance 100%) |
Bum- Joon Kim (Attendance 100%) |
|||
| Agree/Disagree | ||||||
| 2024.02.23 | Approval of the company’s performance evaluation and compensation for 2023 |
Approved | Agree | Agree | Agree | - |
| Approval of the company’s performance evaluation plan and compensation plan for 2024 |
Approved | Agree | Agree | Agree | - | |
| 2025.02.17 | Designation of the Chairman of Committee for Evaluation & Compensation Committee Operation |
Approved | - | Agree | Agree | Agree |
| Approval of the company’s performance evaluation and compensation for 2024 |
Approved | - | Agree | Agree | Agree | |
| 2025.03.06 | Approval of the company’s performance evaluation plan and compensation plan for 2025 |
Approved | - | Agree | Agree | Agree |
As of May. 31, 2025
| Date | Agenda | Recognition | Member of the Committee | ||||
|---|---|---|---|---|---|---|---|
| Bum-Joon Kim (Attendance 100%) |
Hak-Joon Kim (Attendance 100%) |
Byung-Won Jang (Attendance 100%) |
Dong-Chul Kim (Attendance 100%) |
Dae-Woo Lee (Attendance 100%) |
|||
| Agree/Disagree | |||||||
| 2024.08.28 | Appointment of the Chairman of the ESG Committee | Approved | Agree | Agree | Agree | Agree | Agree |
| Conclusion of Exclusive Sales Agreement with Ecowin | Approved | Agree | Agree | Agree | Agree | Agree | |
| Approval and Reporting of Transaction Limits with Related Parties | Approved | Agree | Agree | Agree | Agree | Agree | |
| Report on ESG Management Operations for the First Half of 2024 | - | Attended | Attended | Attended | Attended | Attended | |
| Report on ESG Management Operation Plan for the Second Half of 2024 | - | Attended | Attended | Attended | Attended | Attended | |
| 2024.12.11 | Approval of the Publication Plan for the Sustainability Report | Approved | Agree | Agree | Agree | Agree | Agree |
| Approval of the Materiality Assessment Plan for 2024 | Approved | Agree | Agree | Agree | Agree | Agree | |
| Report on the ESG Evaluation Status for 2024 | - | Attended | Attended | Attended | Attended | Attended | |
| 2025.02.06 | Prior Approval of Internal Transactions for 2025 | Approved | Agree | Agree | Agree | Agree | Agree |
| Report on Internal Transaction Results for 2024 | - | Attended | Attended | Attended | Attended | Attended | |
| Report on the Results of the Materiality Assessment for 2024 | - | Attended | Attended | Attended | Attended | Attended | |
| 2025.03.06 | Approval of the ESG Management Plan for 2025 | Approved | Agree | Agree | Agree | Agree | Agree |
| Report on ESG Management Performance for 2024 | - | Attended | Attended | Attended | Attended | Attended | |
| Interim Report on the 2024 Sustainability Management Report | - | Attended | Attended | Attended | Attended | Attended | |
| 2025.05.28 | Appointment of the Chairman of the ESG Committee | Approved | Agree | Agree | Agree | Agree | Agree |
| Approval of the FY2024 Corporate Governance Report | Approved | Agree | Agree | Agree | Agree | Agree | |
※ Refer to Audit Organization
As of Mar 31, 2025
| Category | Name | Appointed on | Term | Careers |
|---|---|---|---|---|
| Audit Committee member (chairman) |
Bum-Joon Kim | March 31, 2025 | 3 years | Professor, The Catholic University of Korea Member, Statutory Interpretation and Deliberation Committee, Financial Services Commission |
| Audit Committee member | Byung-Won Jang | March 26, 2024 | 3 years | Adjunct Professor, Ajou University College of Pharmacy Vice President, Korea Pharmaceutical and Bio-Pharma Manufacturers Association |
| Audit Committee member | Dong-Chul Kim | March 26, 2024 | 3 years | Managing Partner Attorney, Law firm HYUN Ltd. Member, Seoul City Private Investment Evaluation Committee |
As of May. 31, 2025
| Date | Agenda | Recognition | Member of the Committee | ||
|---|---|---|---|---|---|
| Bum- Joon Kim (Attendance : 100%) |
Byung- Won Jang (Attendance : 100%) |
Dong- Chul Kim (Attendance : 100%) |
|||
| Agree/Disagree | |||||
| 2025.01.20 | Approval of the Proposed Amendment to the Documentation Related to the Appointment of the External Auditor | Approved | Agree | Agree | Agree |
| Appointment of External Auditor | Approved | Agree | Agree | Agree | |
| 2025.02.19 | Report on the Operational Status of the Internal Accounting Management System for 2024 | - | Attended | Attended | Attended |
| Report on the Operational Status of Internal Audit Controls for 2024 | - | Attended | Attended | Attended | |
| 2025.03.06 | Approval of the Evaluation Report on the Operational Status of the Internal Accounting Management System for 2024 | Approved | Agree | Agree | Agree |
| Approval of the Evaluation Opinion on Internal Audit Controls for 2024 | Approved | Agree | Agree | Agree | |
| Approval of the Audit Report by the Audit Committee for 2024 | Approved | Agree | Agree | Agree | |
| Confirmation of Agenda Items and Document Review Opinions for the 12th Annual General Meeting of Shareholders | Approved | Agree | Agree | Agree | |
| 2025.05.08 | Appointment of the Chairman of the Audit Committee | Approved | Agree | Agree | Agree |
| Approval of the Post-Evaluation of the External Auditor for 2024 | Approved | Agree | Agree | Agree | |
| Approval of the Financial Statements for 1Q 2025 | Approved | Agree | Agree | Agree | |
| 2025.05.28 | Report on the results of the 2025 Internal Accounting manager qualification assessment | - | Attended | Attended | Attended |
| Report on the plan of Internal Accounting Management System for 2025 | - | Attended | Attended | Attended | |
As of Dec. 31, 2024
| Date | Agenda | Recognition | Member of the Committee | ||||
|---|---|---|---|---|---|---|---|
| Bum- Joon Kim (Attendance : 100%) |
Hee- Joo Choi (Attendance : 100%) |
Jae- Sang Ryu (Attendance : 100%) |
Byung- Won Jang (Attendance : 100%) |
Dong- Chul Kim (Attendance : 100%) |
|||
| Agree/Disagree | |||||||
| 2024.02.23 | FY2023 Report on operational status of the Internal Accounting Control system | Reported | Attended | Attended | Attended | - | - |
| FY2023 Report on the operational status of the internal Monitoring system | Reported | Attended | Attended | Attended | - | - | |
| 2024.03.07 | Approval of Evaluation Report on the operational status of the Internal Accounting Control System | Approved | Agree | Agree | Agree | - | - |
| Approval of Evaluation Report on the operational status of the Internal Monitoring System | Approved | Agree | Agree | Agree | - | - | |
| Report of 2023 2nd half internal audit results and operation status of the internal complaint system | Reported | Attended | Attended | Attended | - | - | |
| Approval of 2024 annual internal audit plan | Approved | Agree | Agree | Agree | - | - | |
| 2024.03.14 | Approval of audit report | Approved | Agree | Agree | Agree | - | - |
| Approval of the document investigation on 11th annual meeting of shareholders | Approved | Agree | Agree | Agree | - | - | |
| 2024.05.09 | Approval of post evaluation by external auditor in FY2023 | Approved | Agree | - | - | Agree | Agree |
| Report on the results of the Internal Accounting Control System manager qualification evaluation | Reported | Attended | - | - | Attended | Attended | |
| Approval of 2024 1Q Settlement of Accounts | Approved | Agree | - | - | Agree | Agree | |
| Report on the plan of Internal Accounting Control System for 2024 | Reported | Attended | - | - | Attended | Attended | |
| 2024.08.06 | FY2024 Approval of the Review Opinion on the Agenda and Documents for the Extraordinary Shareholders’ Meeting | Approved | Agree | - | - | Agree | Agree |
| 2024.08.08 | Approval of 2024 2Q Settlement of Accounts | Approved | Agree | - | - | Agree | Agree |
| FY2024 Report on internal Accounting Control System Design effectiveness | Reported | Attended | - | - | Attended | Attended | |
| Report on the results of the internal audit for the first half of 2024 | Reported | Attended | - | - | Attended | Attended | |
| 2024.11.07 | Approval of the Financial Statements for 3Q 2024 | Approved | Agree | - | - | Agree | Agree |
| Conclusion of Non-Audit Service Contract with External Auditor | Approved | Agree | - | - | Agree | Agree | |
| Consent for the Appointment and Dismissal of the Head of the Internal Audit Department | Approved | Agree | - | - | Agree | Agree | |
| Report on the 2024 First Half Evaluation of the Internal Accounting Management System | - | Attended | - | - | Attended | Attended | |
| 2024.12.11 | Amendment of the Internal Accounting Management Regulations | Approved | Agree | - | - | Agree | Agree |
| Report on the Results of the Internal Audit and Operation Status of the Whistleblower System for the Second Half of 2024 | - | Attended | - | - | Attended | Attended | |
| Approval of the Annual Internal Audit Plan for 2025 | Approved | Agree | - | - | Agree | Agree | |
| 회차 | 개최일자 | 의안내용 | 가결 여부 |
감사위원의 성명 | |||
|---|---|---|---|---|---|---|---|
| 김범준 (출석률 : 100%) |
최희주 (출석률 : 100%) |
류재상 (출석률 : 100%) |
|||||
| 찬반여부 | |||||||
| 1 | 2023.02.24 | 내부회계관리자 임명 동의의 건 | 가결 | 찬성 | 찬성 | 찬성 | |
| FY2022 대표이사의 내부회계관리제도 운영실태 보고의 건 | - | 참석 | 참석 | 참석 | |||
| FY2022 내부감시장치 운영현황 보고의 건 | - | 참석 | 참석 | 참석 | |||
| FY2022 하반기 내부감사 결과 보고의 건 | - | 참석 | 참석 | 참석 | |||
| FY2022 내부고발제도 운영 현황 보고의 건 | - | 참석 | 참석 | 참석 | |||
| FY2023 내부감사 연간 계획 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | |||
| 2 | 2023.03.09 | FY2022 내부회계관리제도 운영실태 평가보고서 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | |
| FY2022내부감시장치에 대한 평가의견서 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | |||
| 3 | 2023.03.17 | FY2022 감사보고서 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | |
| 제10기 정기주총 의안 및 서류 조사의견 확정의 건 | 가결 | 찬성 | 찬성 | 찬성 | |||
| 4 | 2023.05.11 | FY2023 1분기 결산 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | |
| FY2022 외부감사인 사후평가 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | |||
| FY2023 내부회계관리 계획 보고 | - | 참석 | 참석 | 참석 | |||
| 5 | 2023.08.10 | FY2023 2분기 결산 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | |
| FY2023 상반기 내부감사 보고의 건 | - | 참석 | 참석 | 참석 | |||
| 6 | 2023.11.09 | FY2023 3 분기 결산 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | |
| FY2023 상반기 내부회계관리 운영평가 보고의 건 | - | 참석 | 참석 | 참석 | |||
| 7 | 2023.12.19 | 외부감사인 용역 체결의 건 | 가결 | 찬성 | 찬성 | 찬성 | |
| 회차 | 개최일자 | 의안내용 | 가결 여부 |
감사위원의 성명 | |||
|---|---|---|---|---|---|---|---|
| 김범준 (출석률 100%) |
최희주 (출석률 100%) |
류재상 (출석률 100%) |
김근수 (출석률 100%) |
||||
| 찬반여부 | |||||||
| 1 | 2022.01.28 | FY2020년 외부감사인 사후평가 승인의 건 | 가결 | - | 찬성 | 찬성 | 찬성 |
| 외부감사인 선정의 건 | 가결 | - | 찬성 | 찬성 | 찬성 | ||
| 2 | 2022.01.28 | 대표이사의 내부회계관리제도 운영실태 보고의 건 | - | - | 참석 | 참석 | 참석 |
| 내부감시장치 운영현황 보고의 건 | - | - | 참석 | 참석 | 참석 | ||
| 3 | 2022.02.25 | 내부회계관리제도 운영실태 평가보고서 승인의 건 | 가결 | - | 찬성 | 찬성 | 찬성 |
| 내부감시장치에 대한 평가의견서 승인의 건 | 가결 | - | 찬성 | 찬성 | 찬성 | ||
| 2021년 하반기 내부감사 보고의 건 | - | - | 참석 | 참석 | 참석 | ||
| 2022년 상반기 내부감사 계획 승인의 건 | 가결 | - | 찬성 | 찬성 | 찬성 | ||
| 4 | 2022.03.21 | 감사보고서 승인의 건 | 가결 | - | 찬성 | 찬성 | 찬성 |
| 제9기 정기주주총회 의안 및 서류 조사의견 확정의 건 | 가결 | - | 찬성 | 찬성 | 찬성 | ||
| 5 | 2022.03.28 | 감사위원회 위원장 선임의 건 | 가결 | 찬성 | 찬성 | 찬성 | - |
| 6 | 2022.05.12 | 2022년 1분기 결산 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | - |
| 2022년 내부회계관리 계획 보고 | - | 참석 | 참석 | 참석 | - | ||
| 7 | 2022.08.11 | 2022년 2분기 결산 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | - |
| FY2021년 외부감사인 사후평가 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | - | ||
| 2022년 상반기 내부감사결과 보고의 건 | - | 참석 | 참석 | 참석 | - | ||
| 2022년 하반기 감사계획 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | - | ||
| 8 | 2022.11.10 | 2022년 3분기 결산 승인의 건 | 가결 | 찬성 | 찬성 | 찬성 | - |
| 보유세 조세불복 용역계약 체결의 건 | 가결 | 찬성 | 찬성 | 찬성 | - | ||
| 2022년 내부회계관리자 적격성 평가 결과 보고의 건 | - | 참석 | 참석 | 참석 | - | ||
| 내부회계관리자 승계 계획(안) | 가결 | 찬성 | 찬성 | 찬성 | - | ||
| 2022년 상반기 내부회계관리제도 운영실태 보고의 건 | - | 참석 | 참석 | 참석 | - | ||
| External Auditor | Date of appointment | Term | Note |
|---|---|---|---|
| Samil PwC | 2025.02.03 | 3 fiscal year (FY2025~FY2027) |
Reappointment |
| Fiscal Year | External Auditor | Audit Opinion | Note |
|---|---|---|---|
| FY2024 | Samil PwC | Unqualified | - |
| FY2023 | Samil PwC | Unqualified | - |
| FY2022 | Samil PwC | Unqualified | - |
As of Dec. 31, 2024
Listed
Unlisted
| No | Title | Date Created | Attachment |
|---|---|---|---|
| 8 | 2024 Corporate Governance Report | 2025-05-31 | 첨부파일 다운로드 |
| 7 | 2023 Corporate Governance Report | 2024-05-31 | 첨부파일 다운로드 |
| 6 | 2022 Corporate Governance Report | 2023-05-31 | 첨부파일 다운로드 |
| 5 | 2021 Corporate Governance Report | 2022-05-31 | 첨부파일 다운로드 |
| 4 | 2020 Corporate Governance Report | 2021-05-31 | 첨부파일 다운로드 |
| 3 | 2019 Corporate Governance Report | 2020-05-29 | 첨부파일 다운로드 |
| 2 | 2018 Corporate Governance Report | 2019-05-31 | 첨부파일 다운로드 |
| 1 | 2017 Corporate Governance Report | 2018-06-01 | 첨부파일 다운로드 |
